Speciality pharma group Alliance Pharma PLC (LON:APH) has appointed two new non-executive directors to its board.
Alliance said the appointments of Jo Le Couilliard and Richard Jones will add further international business experience and capital markets expertise.
READ: Alliance happy with two-pronged strategy
Le Couilliard spent most of her career at FTSE 100 drugmaker GlaxoSmithKline PLC (LON:GSK), while former investment banker Jones is the current chief financial officer of Mereo Biopharma Group PLC (LON:MPH).
Both directors qualified as accountants at Big Four accounting firm PricewaterhouseCoopers (PwC).
“I am delighted to welcome Jo and Richard to Alliance's board,” said chairman David Cook.
“They bring a huge breadth of relevant and varied experience to Alliance. Jo's extensive experience at GSK included a senior sales and marketing position in Asia Pacific, which represents Alliance's fastest growing region.
“Richard, from his work as an investment banker and as a financial executive, brings a depth of relevant capital markets experience. I look forward to their contribution to the company's ongoing development into a leading international healthcare business.”
Alliance shares were flat at 67.2p in early deals on Monday.